Fierce Healthcare April 27, 2022
Anastassia Gliadkovskaya

The pace of healthcare and life sciences mergers and acquisitions has slowed, according to KPMG’s latest report.

The report, which examines the dealmaking pace for the first quarter of 2022, found this quarter’s deal volume has declined by 34% to 427 deals compared to the fourth quarter of 2021. Private equity has pulled back the most, making 50% fewer deals.

“Deal activity is still reasonably robust, it’s just not frantic like it has been for the last 12 to 15 months,” Ross Nelson, head of KPMG’s healthcare strategy practice, told Fierce Healthcare.

Amid the Russia-Ukraine war, global supply chain issues, inflation and rising interest rates in the U.S., private equity investors are expected to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Digital Health, Health IT, Health System / Hospital, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Provider, Survey / Study, Technology, Telehealth, Trends
Related Articles:
Biopharma M&A more than doubled in the first quarter compared to the year prior: report
Private equity bankruptcies in healthcare explode 112% in 5 years
Private equity-backed radiology provider Solis Mammography inks joint venture deal with large hospital system
VITAS Closes $85M Covenant Health Transaction
Bruker brokers $392M deal for frayed NanoString

Share This Article